Securities
We're currently building out coverage for Swiss-listed stocks (SIX Exchange). Other markets will follow.

Bachem Holding AG

CH1176493729 · BANBSIX · 🇨🇭 CH · Healthcare · Stock

Bachem Holding AG is a Swiss biopharmaceutical company headquartered in Bubendorf, Switzerland, specializing in the development and manufacture of peptides and oligonucleotides for the pharmaceutical and biotechnology industries. The company supplies active pharmaceutical ingredients (APIs) and provides peptide chemistry services across the full development lifecycle, from early research through to commercial-scale production. Bachem is recognized as one of the world's leading independent providers of peptide-based APIs and has a global presence with facilities across Europe, North America, and Asia.

Last Dividend

0.45

CHF · 2026-05-04

5Y Growth

-15.66%

CAGR

Frequency

Annual

Years Paid

4

consecutive

Not Cut

2

consecutive yrs

Grown

2

consecutive yrs

Listings

Exchange Ticker Currency
SIX primary
BANB CHF

Annual Dividends

CHF 0.75
2023
CHF 0.40
2024
CHF 0.42
2025
CHF 0.45
2026

Annual dividend per share · 4 years of data

Dividend History

Ex-Date Pay-Date Amount Type
04.05.202606.05.20260.45 CHFOrdinary
05.05.202507.05.20250.42 CHFOrdinary
26.04.202430.04.20240.40 CHFOrdinary
21.04.202325.04.20230.38 CHFOrdinary
21.04.202325.04.20230.37 CHFOrdinary